American Society of Clinical Oncology issues annual report on state of clinical cancer science

The American Society of Clinical Oncology (ASCO) has just released its annual report on the top cancer advances of the year. Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, highlights major achievements in precision medicine, cancer screening and overcoming treatment resistance.

"Consistent, significant achievements are being made in oncology care with novel therapeutics, even in malignancies that have previously had few treatment options, as well as defining factors that will predict for response to treatment. ASCO's report distills the most significant of these advances that are impacting the lives of cancer patients today," said Bruce Roth, MD, Co-Executive Editor of the report."

Many of the top clinical research advances of 2012 involve therapeutic approaches that stem from our growing understanding of the complex biology of cancer, which enables development of targeted drugs and treatments tailored to molecular characteristics of individual patients and their tumors. This research has led to seven new FDA approvals for anticancer agents in 2012, some of which will help patients with treatment-resistant forms of cancer.

The top cancer advances from this year include:

  • Two new therapies which delay progression of – One study found adding targeted therapy to hormonal therapy delays disease progression in postmenopausal women with advanced hormone receptor-positive
  • Another advance was an armed antibody or "" approach called TDM-1 to selectively deliver medicine to HER2-positive , leaving healthy cells alone
  • Research finding that pre-operative chemotherapy and radiation improves survival for patients with esophageal cancer
  • A study showing screening with reduces colorectal and death rates
  • Research showing a new targeted treatment extends survival for patients with advanced prostate cancer
The large number of advances featured in this year's report showcase the payoff of the national investment in clinical cancer research on prevention, screening, survival and quality of life for patients with cancer. The report, now in its eighth year, features 87 studies, 17 of which were designated as major advances by the report's 21-person editorial board.

This year's report also contains "The Policy Environment: ASCO in Action in 2012" section, which outlines some of the key cancer policy issues facing physicians and patients, including addressing the nation's cancer drug shortages and ensuring all patients have access to high-quality care. Additional topics covered in this section include ASCO's initiative to build a rapid learning system for oncology called CancerLinQ and the Society's recommendations for improving quality and value in cancer care through the Choosing Wisely campaign and ASCO's Top Five list.

More information: Download a fully interactive copy of the Clinical Cancer Advances 2012 report at www.cancerprogress.net/cca

add to favorites email to friend print save as pdf

Related Stories

New target, new drug in breast cancer

Jun 04, 2012

Many breast cancers depend on hormones including estrogen or progesterone for their survival and proliferation. Eight years of lab work at the University of Colorado Cancer Center and elsewhere suggest that the androgen (AR) ...

Recommended for you

Taking the guesswork out of cancer therapy

2 hours ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

3 hours ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

4 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

Computer model reveals cancer's energy source

5 hours ago

(Medical Xpress)—A computer model study reveals – for the first time – details of an energy-creating process vital and unique to cancer cells. The research holds promise for new interventions and for ...

User comments